519242 SRDAPRT

Sarda Proteins Share Price

₹113.20 0.00 (0.00%)

20 Jan, 2025 16:49

SIP TrendupStart SIP in SRDAPRT

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month 0%
  • Over 3 Month + 10.17%
  • Over 6 Month + 21.41%
  • Over 1 Year + 51.38%
SIP Lightning

Smart Investing Starts Here Start SIP with Sarda Proteins for Steady Growth!

Invest Now

Sarda Proteins Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Sarda Proteins Financials

Sarda Proteins Technicals

EMA & SMA

Current Price
₹113.20
0 (0%)
pointer
  • stock-down_img
  • Bearish Moving Average 1
  • stock-up_img
  • Bullish Moving Average 15
  • 20 Day
  • ₹105.58
  • 50 Day
  • ₹90.90
  • 100 Day
  • ₹76.35
  • 200 Day
  • ₹66.01

Resistance and Support

113.2 Pivot Speed
  • R3 113.20
  • R2 113.20
  • R1 113.20
  • S1 113.20
  • S2 113.20
  • S3 113.20

What's your outlook on Sarda Proteins?

You can only vote for once

Sarda Proteins Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-01-17 Quarterly Results
2024-12-24 Preferential Issue of shares & Warrents
2024-11-08 Quarterly Results
2024-08-12 Quarterly Results
2024-04-30 Audited Results

Sarda Proteins F&O

Sarda Proteins Shareholding Pattern

No data available.

About Sarda Proteins

  • NSE Symbol
  • SRDAPRT
  • BSE Symbol
  • 519242
  • ISIN
  • INE995U01011

Similar Stocks to Sarda Proteins

Sarda Proteins FAQs

Sarda Proteins share price is ₹113 As on 20 January, 2025 | 16:35

The Market Cap of Sarda Proteins is ₹19.5 Cr As on 20 January, 2025 | 16:35

The P/E ratio of Sarda Proteins is 137.8 As on 20 January, 2025 | 16:35

The PB ratio of Sarda Proteins is 12.3 As on 20 January, 2025 | 16:35

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23